CytomX Therapeutics (CTMX) Short Interest Ratio & Short Volume

$1.93
+0.04 (+2.12%)
(As of 03:10 PM ET)

CytomX Therapeutics Short Interest Data

Current Short Interest
3,600,000 shares
Previous Short Interest
3,590,000 shares
Change Vs. Previous Month
+0.28%
Dollar Volume Sold Short
$5.87 million
Short Interest Ratio
0.6 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
77,920,000 shares
Percentage of Shares Shorted
4.62%
Today's Trading Volume
1,237,526 shares
Average Trading Volume
4,404,580 shares
Today's Volume Vs. Average
28%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling CytomX Therapeutics ?

Sign up to receive the latest short interest report for CytomX Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CTMX Short Interest Over Time

CTMX Days to Cover Over Time

CTMX Percentage of Float Shorted Over Time

CytomX Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20243,600,000 shares $5.87 million +0.3%N/A0.6 $1.63
4/15/20243,590,000 shares $7.07 million +8.1%N/A4 $1.97
3/31/20243,320,000 shares $7.24 million -6.0%N/A3.8 $2.18
3/15/20243,530,000 shares $7.31 million +115.2%N/A4.1 $2.07
2/29/20241,640,000 shares $4.02 million +26.2%N/A2.2 $2.45
2/15/20241,300,000 shares $1.95 million +4.0%N/A2.8 $1.50
1/31/20241,250,000 shares $1.91 million -5.3%N/A4.2 $1.53
1/15/20241,320,000 shares $2.28 million -0.8%N/A4.4 $1.73
12/31/20231,330,000 shares $2.06 million +35.5%N/A4.9 $1.55
12/15/2023981,600 shares $1.38 million -26.8%N/A5 $1.41
11/30/20231,340,000 shares $1.86 million +0.8%N/A7.5 $1.39
11/15/20231,330,000 shares $1.72 million +5.6%N/A8 $1.29
10/31/20231,260,000 shares $1.39 million -18.2%N/A7 $1.10
10/15/20231,540,000 shares $1.93 million -9.9%N/A8.5 $1.25
9/30/20231,710,000 shares $2.21 million -23.0%N/A9.5 $1.29
9/15/20232,220,000 shares $3.06 million +2.3%N/A8.2 $1.38
8/31/20232,170,000 shares $3.26 million +5.9%N/A7.5 $1.50
8/15/20232,050,000 shares $3.26 million -21.5%N/A6.5 $1.59
7/31/20232,610,000 shares $4.54 million -3.0%4.0%7 $1.74
7/15/20232,690,000 shares $4.90 million +13.0%4.1%6.8 $1.82
6/30/20232,380,000 shares $4.09 million No Change3.7%5.3 $1.72
6/15/20232,380,000 shares $3.71 million +4.4%3.7%4.5 $1.56
5/31/20232,280,000 shares $3.90 million +7.0%3.5%3.4 $1.71
5/15/20232,130,000 shares $3.88 million -13.4%3.3%2.8 $1.82
4/30/20232,460,000 shares $4.01 million +9.3%3.8%2.8 $1.63
4/15/20232,250,000 shares $3.74 million +40.6%3.5%2 $1.66
3/31/20231,600,000 shares $2.42 million -14.9%2.5%1 $1.51
3/15/20231,880,000 shares $3.82 million +48.0%2.9%0.8 $2.03
2/28/20231,270,000 shares $2.73 million -8.0%2.0%0.5 $2.15
2/15/20231,380,000 shares $3.20 million -13.8%2.1%0.5 $2.32
1/31/20231,600,000 shares $4.32 million -43.3%2.5%0.5 $2.70
1/15/20232,820,000 shares $8.07 million +433.7%4.3%1 $2.86
12/30/2022528,400 shares $845,440.00 -64.1%0.8%0.2 $1.60
12/15/20221,470,000 shares $2.34 million -26.1%2.3%1.1 $1.59
11/30/20221,990,000 shares $3.46 million +103.7%3.1%1.6 $1.74
11/15/2022977,100 shares $1.16 million -2.0%1.5%0.8 $1.19
10/31/2022997,400 shares $1.31 million -6.8%1.6%2 $1.31
10/15/20221,070,000 shares $1.52 million -10.8%1.7%1.6 $1.42
9/30/20221,200,000 shares $1.74 million +2.6%1.9%1.3 $1.45
9/15/20221,170,000 shares $1.94 million +30.9%1.9%0.7 $1.66
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide
8/31/2022894,100 shares $1.34 million -14.0%1.4%0.5 $1.50
8/15/20221,040,000 shares $1.80 million -21.2%1.7%0.6 $1.73
7/31/20221,320,000 shares $1.89 million +1.5%2.1%0.7 $1.43
7/15/20221,300,000 shares $1.95 million +10.2%2.1%0.7 $1.50
6/30/20221,180,000 shares $2.16 million -67.7%1.9%0.7 $1.83
6/15/20223,650,000 shares $6.28 million -4.5%5.9%3.2 $1.72
5/31/20223,820,000 shares $6.15 million -5.5%6.1%3.5 $1.61
5/15/20224,040,000 shares $7.11 million +6.3%6.5%3.8 $1.76
4/30/20223,800,000 shares $6.50 million +37.7%6.2%3.9 $1.71
4/15/20222,760,000 shares $6.38 million -29.6%4.5%3.2 $2.31
3/31/20223,920,000 shares $10.47 million +2.6%6.4%4.4 $2.67
3/15/20223,820,000 shares $11.38 million No Change6.3%3.2 $2.98
2/28/20223,820,000 shares $14.63 million -2.1%6.3%3.4 $3.83
2/15/20223,900,000 shares $15.91 million +11.4%6.4%3.2 $4.08
1/31/20223,500,000 shares $16.10 million -5.4%5.6%2.7 $4.60
1/15/20223,700,000 shares $14.62 million +19.4%5.9%2.9 $3.95
12/31/20213,100,000 shares $13.42 million -22.3%5.0%2.6 $4.33
12/15/20213,990,000 shares $26.65 million +9.0%6.4%3.6 $6.68
11/30/20213,660,000 shares $24.19 million -21.8%5.9%5.3 $6.61
11/15/20214,680,000 shares $33.98 million -3.3%7.5%7.6 $7.26
10/29/20214,840,000 shares $28.70 million +7.6%7.7%8.1 $5.93
10/15/20214,500,000 shares $23.13 million -7.4%7.2%8.1 $5.14
9/30/20214,860,000 shares $24.74 million -7.3%7.7%8.1 $5.09
9/15/20215,240,000 shares $26.04 million -11.2%8.3%7.6 $4.97
8/31/20215,900,000 shares $30.21 million -11.7%9.4%8.6 $5.12
8/13/20216,680,000 shares $32.40 million -4.4%10.6%9.2 $4.85
7/30/20216,990,000 shares $37.82 million +5.1%10.9%9.3 $5.41
7/15/20216,650,000 shares $39.10 million +0.2%10.4%7.5 $5.88
6/30/20216,640,000 shares $42.03 million -0.6%10.4%7 $6.33
6/15/20216,680,000 shares $47.29 million +0.6%10.5%7.2 $7.08
5/28/20216,640,000 shares $47.54 million -1.3%10.4%6.8 $7.16
5/14/20216,730,000 shares $55.39 million +1.1%N/A6.8 $8.23
4/30/20216,660,000 shares $63.20 million +7.6%N/A6.6 $9.49
4/15/20216,190,000 shares $44.69 million -3.4%N/A6.2 $7.22
3/31/20216,410,000 shares $47.43 million +63.5%N/A6.2 $7.40
3/15/20213,920,000 shares $33.32 million +17.7%N/A3.9 $8.50
2/26/20213,330,000 shares $26.17 million No ChangeN/A3.7 $7.86
2/12/20213,330,000 shares $27.44 million -8.5%N/A3.9 $8.24
1/29/20213,640,000 shares $25.52 million +20.9%N/A4.6 $7.01
1/15/20213,010,000 shares $23.63 million +3.8%N/A4.4 $7.85
12/31/20202,900,000 shares $19.78 million -3.3%6.5%6.2 $6.82
12/15/20203,000,000 shares $23.70 million -8.8%6.7%6.8 $7.90
11/30/20203,290,000 shares $24.41 million -10.1%7.4%7.9 $7.42
11/15/20203,660,000 shares $27.08 million -7.3%8.2%9 $7.40
10/30/20203,950,000 shares $26.74 million +16.2%8.8%9.7 $6.77
10/15/20203,400,000 shares $23.02 million +10.8%7.6%8 $6.77
9/30/20203,070,000 shares $20.42 million -7.0%6.8%7.2 $6.65
9/15/20203,300,000 shares $23.83 million -6.0%7.4%7.3 $7.22
8/31/20203,510,000 shares $25.62 million +5.7%7.8%7.3 $7.30
8/14/20203,320,000 shares $22.78 million +3.1%7.4%6.1 $6.86
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide
7/31/20203,220,000 shares $22.57 million +20.6%7.2%5.1 $7.01
7/15/20202,670,000 shares $22.83 million -15.8%6.0%4 $8.55
6/30/20203,170,000 shares $26.41 million +88.7%7.2%4.7 $8.33
6/15/20201,680,000 shares $13.37 million +40.0%3.8%2.4 $7.96
5/29/20201,200,000 shares $10.63 million +1.7%2.7%1.8 $8.86
5/15/20201,180,000 shares $10.63 million +10.3%2.7%1.8 $9.01
4/30/20201,070,000 shares $11.04 million -14.4%2.4%2 $10.32
4/15/20201,250,000 shares $10.96 million +44.6%2.8%2.6 $8.77
3/31/2020864,300 shares $8.04 million -39.3%2.0%1.9 $9.30
3/13/20201,423,800 shares $12.20 million +11.2%3.2%3.1 $8.57
2/28/20201,280,000 shares $6.31 million +10.3%2.9%3 $4.93
2/14/20201,160,000 shares $7.49 million -11.5%2.6%2.7 $6.46
1/31/20201,310,000 shares $9.51 million -14.9%3.0%3 $7.26
1/15/20201,540,000 shares $11.18 million -1.3%3.5%3.5 $7.26
12/31/20191,560,000 shares $11.70 million -32.8%3.5%3.2 $7.50

CTMX Short Interest - Frequently Asked Questions

What is CytomX Therapeutics' current short interest?

Short interest is the volume of CytomX Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 3,600,000 shares of CTMX short. Learn More on CytomX Therapeutics' current short interest.

What is a good short interest ratio for CytomX Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CTMX shares currently have a short interest ratio of 1.0. Learn More on CytomX Therapeutics's short interest ratio.

Which institutional investors are shorting CytomX Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CytomX Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is CytomX Therapeutics' short interest increasing or decreasing?

CytomX Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 3,600,000 shares, an increase of 0.3% from the previous total of 3,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does CytomX Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CytomX Therapeutics: Skye Bioscience, Inc. (0.13%), CervoMed Inc. (1.06%), I-Mab (1.43%), Renovaro Inc. (2.09%), InterCure Ltd. (0.15%), Repare Therapeutics Inc. (2.38%), Syros Pharmaceuticals, Inc. (7.79%), ProQR Therapeutics (0.41%), scPharmaceuticals Inc. (17.76%), Prelude Therapeutics Incorporated (2.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short CytomX Therapeutics stock?

Short selling CTMX is an investing strategy that aims to generate trading profit from CytomX Therapeutics as its price is falling. CTMX shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against CytomX Therapeutics?

A short squeeze for CytomX Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CTMX, which in turn drives the price of the stock up even further.

How often is CytomX Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTMX, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CTMX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners